Tag Archives: Cannabis Science

REVEL Brings Cannabis Innovators to the East Coast

NEW YORK, Jan. 16, 2018 /Weed Wire/ – REVEL, formerly Cannabis Tech Group, is hosting it’s breakout event “Cannabis + Science” on January 25, 2018 in Soho at Galvanize NYC. REVEL has rebranded and reformatted to a “TED Talk”-style cannabis innovation showcase.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science, Inc. Receives U.S. Federal Government Clearance to Receive U.S. Federal Government Contracts

IRVINE, California, May 26, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, has received U.S. Federal Government clearance to receive U.S. Federal Government contracts.

Cannabis Science CBIS U.S. Federal Government Clearance

CBIS Pushes Up the Seeding Schedule Next Month to 350 Acres Set to Include Additional 100 Acres in Minden Carson Valley Property Along with the San Joaquin Valley Property for its Industrial Commercial Hemp Grow Initiatives

IRVINE, Calif., April 17, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has negotiated a deal to begin seeding the 100 Acres in Minden County Nevada adding to the 250 acres of farm lands in the San Joaquin Valley, California for its Industrial Commercial Hemp Grow Initiatives.

Cannabis Science CBIS U.S. Federal Government Clearance

CBIS and RCDU Sign Another Large California Cultivation Land Deal for Two Hundred and Fifty Acres, Scheduled to be Seeded all at Once for Maximum Harvest and Research Production

IRVINE, Calif., April 13, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has negotiated a deal with the Members of the Winnemucca Tribe Shoshoni MBS Fee Lands for 250 acres of HRM farm lands in the San Joaquin Valley, California.

Cannabis Science CBIS U.S. Federal Government Clearance

CBIS Ramps Up Production and Releases More New Products to Meet the Substantial Requests From Self-Medicating Patients Across the Country as it Highlights Moonlight Cannabis as its Newest Spotlight Dispensary for the Month of April 2017

IRVINE, Calif., March 27, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that it has substantially increased its production for its self-medicating patient product line distributed through cannabis dispensaries in California.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Senior Executives to Co-Chair Special Session and Deliver a Keynote Speech at the Global Health Catalyst Summit at Harvard Medical School

IRVINE, Calif., March 1, 2017 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce that its President, CEO and Co-Founder, Raymond C. Dabney, will be a keynote speaker and panelist at the Global Health Catalyst (GHC) Summit at Harvard Medical School on April 28-30, 2017.

Crown Baus Capital

Crown Baus Capital Corp. Acquires 100-Acre Investment Participation in Cannabis Science’s California and Nevada Property and Drug Development Projects

BEVERLY HILLS, Calif., Feb. 17, 2017 /Weed Wire/ — Crown Baus Capital Corp. (OTC PINK: CBCA) announces the Company acquires 100-acre investment participation in the Cannabis Science, Inc. (OTC PINK: CBIS) Property and Drug Development Projects spread across California and Nevada.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Orders Multiple Greenhouse Structures for its 2nd Pilot 33,000 Sq. Ft. Drug Development Facility Buildout in Douglas County, Nevada

IRVINE, Calif., Dec. 21, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medications, has started work on its second 33,000 sq. ft. pilot cannabinoid drug development and manufacturing facility in Douglas County, Nevada.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Signs a 320-Acre Allotment Property Development Deal in Humboldt County, Nevada with Members of the Winnemucca Tribal Allotments Led by Chief Bill

IRVINE, Calif., Oct. 26, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) announced it has just signed a new agreement that will provide an additional 320 acres of allotment development land in Humboldt County, Nevada.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Activates Its Critical Financial Security Department to Specialize in the Worldwide Industry Deficiency in Risk Mitigation, Banking, Payment Processing, and Cash and Asset Movement

IRVINE, Calif., Sept. 2, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce the development and opening of the Cannabis Science Financial Security Department.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science and the Research Foundation Begins Protocols for California Legal Patients to Receive the New CBIS MDI Rescue Inhaler for Its First Observational Study Intending to Lead Into Clinical Trials

IRVINE, Calif., Aug. 12, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is happy to announce the intent to seek out 20 – 25 potential candidates suffering from Asthma/COPD and other critical ailments.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables

IRVINE, Calif., Aug. 11, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis based medicines, is happy to announce their first batch order for the previously announced cannabinoid based inhalation medicine for Asthma/COPD has been placed.

Cannabis Science CBIS U.S. Federal Government Clearance

Twenty Acre Indoor/Outdoor Cultivation Facility in Northern California in the Final Stages of Escrow Awaiting Transfer of Ownership to Cannabis Science, Inc.

IRVINE, Calif., Aug. 1, 2016/Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced they are in the final stages of escrow to transfer the 20-acre Northern California cultivation property into its name and commence indoor/outdoor cultivation and production on the land.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Develops Inhalation Medication for Those Suffering Asthma/COPD via Nebulizer, Targets National Markets

IRVINE, Calif., July 29, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce they will release an inhalation medication for those suffering asthma/COPD for use in patient nebulizers.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science 2016 Growth Guidance; Project Briefs, Cash-Flow Projections, and Current Historic Cannabis Industry Advancements; Industry Growth Indicators

IRVINE, Calif., July 20, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to provide its future operations and growth guidance based on its current projects, cash-flow projections, and current historic market advancements.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Guidance; Corporate Headquarters Relocated to California as it Negotiates for a Los Angeles, California Laboratory/Medical Treatment Center

LOS ANGELES, June 30, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced the relocation of their corporate headquarters to Irvine, California.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science’s Mieko Hester-Perez Confirms CBIS Premiere Sponsorship Role at “We Cann Mix,” a Diverse Cannabis Community and Business Mixer Event in Los Angeles, CA

LOS ANGELES, June 23, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced their sponsorship of the “We Cann Mix” event, which is a mixer event intended for patients, advocates, entrepreneurs, scientists, and other enthusiastic members of the cannabis community.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles; Coined, “Cannabis Kills Cancer,” a Celebratory Fund Raiser

LOS ANGELES, June 16, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicine, partners with FHP.TV & Kush Boys Studios to host its “black tie, red carpet” event in Los Angeles.

Cannabis Science CBIS U.S. Federal Government Clearance

Positive Cannabinoid Testing Data in California Prompts Cannabis Science Lab Expansions for IGXBio’s GenePro FDA Investigational New Drug (IND) Number 015982 for Further Drug Development to Identify & Develop Agonist Cannabinoids for GenePro

LOS ANGELES, March 18, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) announces that it is expanding its California clinical drug development operations to work with its partner IGXBio, Inc. in developing effective therapeutics using IGXBio’s Immuonotherapy (GenePro®, also referred to as Δ4SHIVKU2) FDA Investigational New Drug (IND). Number 015982.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science, Inc. (CBIS) Continues to Support CNN’s Dr. Sanjay Gupta for His Ongoing Efforts to Educate the Public on the Effectiveness of Medical Cannabis for Patients in Need

LOS ANGELES, Feb. 29, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) continues to support top surgeon and CNN Medical Correspondent Dr. Sanjay Gupta for his historic and high profile work educating the U.S. and the world about the benefits of medical cannabis and support for the medical cannabis community.

Cannabis Science CBIS U.S. Federal Government Clearance

Cannabis Science Targets Successful Autism Treatments and Brings Family Autism Advocate Mieko Hester-Perez on Its Scientific Advisory Board

COLORADO SPRINGS, Colo., Feb. 8, 2016/ Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced its next critical ailment target is autism and brings Mieko Hester-Perez on its Scientific Advisory Board to lead this charge.

Jimis Meds_CBIS

CBIS & Purple Haze Properties Launch “Jimi’s Meds” eCommerce Website Powered by Cannabis Science and Showcased This Weekend at the High Times Cannabis Cup in Southern California

COLORADO SPRINGS, Colo., Jan. 28, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS) is pleased to announce additional cannabinoid medicinal product releases, this time through its Purple Haze Properties partners focused on a brand new line called “Jimi’s Meds.”

Consumers Becoming More Aware of Hemp’s Nutritional Benefits as Companies Race to Introduce Healthy, Cannabis Infused Beverages

CORAL SPRINGS, Florida, May 20, 2015 /PRNewswire/ — Hemp-based consumer products for the nutraceutical, pharmaceutical and supplement industries continue to evolve as more and more states nationwide soften on restrictions for Legal & Medical Marijuana industries.

South Carolina

Medical Marijuana Gets a Chance and a Hearing in South Carolina

Recent political developments show that South Carolina is giving progress a chance in the form of laws regarding industrial hemp and medical marijuana. On June 2, Gov. Nikki Haley signed bills legalizing industrial hemp and CBD oil.

Cannabidiol “CBD” Strain of Medical Marijuana Establishing New CBD-Oil Nutraceutical Marketplace – Company Aims for Sales of CBD Products in all 50 States

Medical Marijuana and Cannabidiol (CBD Oils) gains momentum towards acceptance as viable medical treatment, significant clinical trial underway for possible seizure treatment and other CBD treatable ailments: Earth Science Tech, Inc. (OTC: ETST), GW Pharmaceuticals plc. (NASDAQ: GWPH), Cannabis Science, Inc. (OTC: CBIS), Easton Pharmaceuticals Inc. (OTC: EAPH) and Hemp, Inc. (OTC: HEMP)

Small Business Operations to Large Scale Companies Take Steps to Increase Security Surveillance – Company Selected for Comprehensive Cannabis Security System Installation

Security and Surveillance needs become top priority in Cannabis / Legal Marijuana industry as sector continues expansion and growth for the following emerging companies: DirectView Holdings, Inc. (OTC: DIRV), Nuvilex, Inc. (OTC: NVLX), GW Pharmaceuticals plc (NASDAQ: GWPH), Singlepoint, Inc. (OTC: SING) and Cannabis Science, Inc. (CBIS).

stock

Pot Stock Caution: Prudence Required

Every day investors look at their stocks and wonder: is this going to be the next big thing? When you are researching potential stocks to buy, it is only natural for your eyes to light up when you see a cannabis-related stock. You may initially think, “Oh boy, this stock is going to be huge!” Don’t let yourself be fooled.


Top